All Stories

  1. Stability of the Influenza Virus Hemagglutinin Protein Correlates with Evolutionary Dynamics

    Article • mSphere, January 2018, ASM Journals

    Dr Eili Y Klein

  2. Identifying the relationship between length of hospital stay and the probability of readmission

    Article • Applied Economics Letters, May 2017, Taylor & Francis

    Dr Eili Y Klein, Professor Michael Makowsky

  3. Bioeconomic analysis of child-targeted subsidies for artemisinin combination therapies: a cost-effectiveness analysis

    Article • Journal of The Royal Society Interface, May 2015, Royal Society Publishing

    Dr Eili Y Klein

  4. Influence of provider and urgent care density across different socioeconomic strata on outpatient antibiotic prescribing in the USA

    Article • Journal of Antimicrobial Chemotherapy, January 2015, Oxford University Press (OUP)

    Dr Eili Y Klein

  5. Germs Are Germs, and Why Not Take a Risk? Patients’ Expectations for Prescribing Antibiotics in an Inner-City Emergency Department

    Article • Medical Decision Making, October 2014, SAGE Publications

    Dr Eili Y Klein

  6. Multisite Exploration of Clinical Decision Making for Antibiotic Use by Emergency Medicine Providers Using Quantitative and Qualitative Methods

    Article • Infection Control and Hospital Epidemiology, September 2014, Cambridge University Press

    Dr Eili Y Klein

  7. Influenza A H1N1 Pandemic Strain Evolution – Divergence and the Potential for Antigenic Drift Variants

    Article • PLoS ONE, April 2014, PLOS

    Dr Eili Y Klein

  8. Shorter Isn't Always Better: Identifying the Relationship between Length of Hospital Stay and the Probability of Readmission

    Article • SSRN Electronic Journal, January 2014, Elsevier

    Professor Michael Makowsky, Dr Eili Y Klein

  9. The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance

    Article • Journal of Theoretical Biology, January 2014, Elsevier

    Dr Eili Y Klein

  10. Disease at the wildlife-livestock interface: Acaricide use on domestic cattle does not prevent transmission of a tick-borne pathogen with multiple hosts

    Article • Veterinary Parasitology, January 2014, Elsevier

    Dr Eili Y Klein

  11. Trends in Antibiotic Resistance in Coagulase-Negative Staphylococci in the United States, 1999 to 2012

    Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

    Dr Eili Y Klein

  12. Cross-Reactive Immune Responses as Primary Drivers of Malaria Chronicity

    Article • Infection and Immunity, October 2013, ASM Journals

    Dr Eili Y Klein

  13. The potential impact of age and season on methicillin-resistant Staphylococcus aureus prevalence

    Article • Future Microbiology, July 2013, Future Medicine

    Dr Eili Y Klein

  14. Policy Resistance Undermines Superspreader Vaccination Strategies for Influenza

    Article • PLoS Computational Biology, March 2013, PLOS

    Dr Eili Y Klein

  15. Trends in Resistance to Carbapenems and Third-Generation Cephalosporins among Clinical Isolates of Klebsiella pneumoniae in the United States, 1999–2010

    Article • Infection Control and Hospital Epidemiology, March 2013, Cambridge University Press

    Dr Eili Y Klein

  16. Hospital-Community Interactions Foster Coexistence between Methicillin-Resistant Strains of Staphylococcus aureus

    Article • PLoS Pathogens, February 2013, PLOS

    Dr Eili Y Klein

  17. Superinfection and the evolution of resistance to antimalarial drugs

    Article • Proceedings of the Royal Society B Biological Sciences, July 2012, Royal Society Publishing

    Dr Eili Y Klein

  18. Relationship between treatment-seeking behaviour and artemisinin drug quality in Ghana

    Article • Malaria Journal, January 2012, Springer Science + Business Media

    Dr Eili Y Klein

  19. Prereferral rectal artesunate for treatment of severe childhood malaria: a cost-effectiveness analysis

    Article • The Lancet, December 2010, Elsevier

    Dr Eili Y Klein

  20. Cost-Effectiveness of “Golden Mustard” for Treating Vitamin A Deficiency in India

    Article • PLoS ONE, August 2010, PLOS

    Dr Eili Y Klein

  21. Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty

    Article • Malaria Journal, July 2010, Springer Science + Business Media

    Dr Eili Y Klein

  22. Should new antimalarial drugs be subsidized?

    Article • Journal of Health Economics, May 2010, Elsevier

    Dr Eili Y Klein

  23. Community-associated Methicillin-Resistant Staphylococcus aureus in Outpatients, United States, 1999–2006

    Article • Emerging Infectious Diseases, December 2009, Centers for Disease Control and Prevention (CDC)

    Dr Eili Y Klein

  24. Optimally timing primaquine treatment to reduce Plasmodium falciparum transmission in low endemicity Thai-Myanmar border populations

    Article • Malaria Journal, July 2009, Springer Science + Business Media

    Dr Eili Y Klein

  25. The burden of vancomycin-resistant enterococcal infections in US hospitals, 2003 to 2004

    Article • Diagnostic Microbiology and Infectious Disease, September 2008, Elsevier

    Dr Eili Y Klein

  26. Clinically immune hosts as a refuge for drug-sensitive malaria parasites

    Article • Malaria Journal, January 2008, Springer Science + Business Media

    Dr Eili Y Klein

  27. Hospitalizations and Deaths Caused by Methicillin-Resistant Staphylococcus aureus , United States, 1999–2005

    Article • Emerging Infectious Diseases, December 2007, Centers for Disease Control and Prevention (CDC)

    Dr Eili Y Klein

  28. Economic incentives and mathematical models of disease

    Article • Environment and Development Economics, October 2007, Cambridge University Press

    Dr Eili Y Klein

  29. Economic benefit of Tuberculosis control

    Article • August 2007

    Christopher Dye, Dr Eili Y Klein

  30. Should New Antimalarial Drugs Be Subsidized?

    Article • SSRN Electronic Journal, Social Science Electronic Publishing

    Dr Eili Y Klein